Despite COVID-19 Lockdowns, Licensed Marijuana Sales Continue in the Vast Majority of States With Legal Pot

By Jacob Sullum Measured by marijuana sales, 4/20 came early this year as cannabis consumers scrambled to stock up, apparently worried that COVID-19 lockdowns might cut off their legal supply. After local governments in the San Francisco Bay Area imposed stay-at-home orders in March, The New York Times reports, sales of edibles “surged to levels typically only seenContinue reading “Despite COVID-19 Lockdowns, Licensed Marijuana Sales Continue in the Vast Majority of States With Legal Pot”

Move Over, Marijuana: Psychedelic Drugs Could Be the Next Big Thing

By Aaron Kesel Several companies that are developing medical treatments from psychedelic drugs like LSD, ketamine, and psilocybin—the active ingredient in magic mushrooms—are getting ready to list on Canadian stock exchanges. One of those companies, Mind Medicine Inc., has been involved in clinical trials of psychedelic-based drugs and aims to list on Toronto’s NEO ExchangeContinue reading “Move Over, Marijuana: Psychedelic Drugs Could Be the Next Big Thing”

Scientists Discover Cannabis Compound That Could Be 30 Times More Potent Than THC

By Elias Marat Are you tired of puffing on flower? Can’t quite afford to lay down the cash for a dabbing rig? Uninterested in the usual edibles? Well, Italian scientists have discovered a previously unknown cannabis compound that has been shown in lab tests to be potentially 30 times stronger than tetrahydrocannabinol (THC), the psychoactiveContinue reading “Scientists Discover Cannabis Compound That Could Be 30 Times More Potent Than THC”

MDMA Inches Away From Becoming FDA-Approved Pharmaceutical

By Truth Theory A set of clinical trials for MDMA, sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) has now reached “Phase 3,” which brings the substance just a few steps away from getting approved by the US Food and Drug Administration (FDA). Only drugs that show promising results during Phase 1 andContinue reading “MDMA Inches Away From Becoming FDA-Approved Pharmaceutical”

The FDA Just Approved a New Drug Application for Cocaine-Based Nasal Spray

By John Vibes In a shocking drug approval last year, the U.S. Food and Drug Administration (FDA) approved a ketamine-based nasal spray for treating depression. The news was surprising considering the history that the substance has as a snortable club drug and the strict policy of drug prohibition and regulation in the U.S. However, in the shortContinue reading “The FDA Just Approved a New Drug Application for Cocaine-Based Nasal Spray”

Design a site like this with WordPress.com
Get started